Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giannella

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Il Farmaco; Edizione Scientifica|July 1, 1982
Molecular requirements of the active sites of the cholinergic receptors. XVIII-Correlation between activity and double bond position among cyclopentene derivativesL Brasili, M Leonelli, M Giannella
Il Farmaco; Edizione Scientifica|April 1, 1980
Molecular requirements of the active sites of the cholinergic receptors. XIII - Stereospecific synthesis of 3c-methyl-2t-hydroxy-lr-dimethyl-aminomethylcyclopentane methiodide and its dehydroderivativeM Giannella, M Leonelli, M Pigini
Il Farmaco; Edizione Scientifica|April 1, 1980
Molecular requirements of the active sites of the cholinergic receptors. XII - 3-Methyl-2-oxo-1-dimethylaminomethylcyclopentane methiodide as a new selective agonist for the nicotinic receptorM Giannella, P Angeli, C Melchiorre, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 17, 2019
Advances in the therapy of bacterial bloodstream infectionsM Giannella, M Bartoletti, M Gatti, et al.
Il Farmaco; Edizione Scientifica|September 1, 1982
Molecular requirements of the active sites of the cholinergic receptors. XIX-Size evaluation of the muscarinic subsiteF Gualtieri, L Brasili, M Giannella, et al.
British Journal of Pharmacology|August 1, 1985
Affinity and efficacy correlate with chemical structure more than potency does in a series of pentatomic cyclic muscarinic agonistsP Angeli, L Brasili, M Giannella, et al.
Journal of Medicinal Chemistry|October 1, 1987
Resolution, absolute configuration, and cholinergic enantioselectivity of (-)- and (+)-c-2-methyl-r-5-[(dimethylamino)methyl]-1,3-oxathiolane t-3-oxide methiodide and related sulfonesE Teodori, F Gualtieri, P Angeli, et al.
Canadian Journal of Physiology and Pharmacology|December 1, 1980
Irreversible alpha adrenoceptor blocking effects and reversible muscarinic blocking and nicotinic blocking effects of tetramine disulfides on the heartB G Benfey, B Belleau, L Brasili, et al.
Drug Design and Delivery|May 1, 1988
Molecular requirements for antimuscarinic activity in 1,3-oxathiolanesP Angeli, D Bacchiocchi, M Giannella, et al.
Journal of Medicinal Chemistry|September 1, 1986
Resolution, absolute configuration, and cholinergic enantioselectivity of (+)- and (-)-cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodideE Teodori, F Gualtieri, P Angeli, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Il Farmaco; Edizione Scientifica|July 1, 1982
Molecular requirements of the active sites of the cholinergic receptors. XVIII-Correlation between activity and double bond position among cyclopentene derivativesL Brasili, M Leonelli, M Giannella
Il Farmaco; Edizione Scientifica|April 1, 1980
Molecular requirements of the active sites of the cholinergic receptors. XIII - Stereospecific synthesis of 3c-methyl-2t-hydroxy-lr-dimethyl-aminomethylcyclopentane methiodide and its dehydroderivativeM Giannella, M Leonelli, M Pigini
Il Farmaco; Edizione Scientifica|April 1, 1980
Molecular requirements of the active sites of the cholinergic receptors. XII - 3-Methyl-2-oxo-1-dimethylaminomethylcyclopentane methiodide as a new selective agonist for the nicotinic receptorM Giannella, P Angeli, C Melchiorre, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 17, 2019
Advances in the therapy of bacterial bloodstream infectionsM Giannella, M Bartoletti, M Gatti, et al.
Il Farmaco; Edizione Scientifica|September 1, 1982
Molecular requirements of the active sites of the cholinergic receptors. XIX-Size evaluation of the muscarinic subsiteF Gualtieri, L Brasili, M Giannella, et al.
British Journal of Pharmacology|August 1, 1985
Affinity and efficacy correlate with chemical structure more than potency does in a series of pentatomic cyclic muscarinic agonistsP Angeli, L Brasili, M Giannella, et al.
Journal of Medicinal Chemistry|October 1, 1987
Resolution, absolute configuration, and cholinergic enantioselectivity of (-)- and (+)-c-2-methyl-r-5-[(dimethylamino)methyl]-1,3-oxathiolane t-3-oxide methiodide and related sulfonesE Teodori, F Gualtieri, P Angeli, et al.
Canadian Journal of Physiology and Pharmacology|December 1, 1980
Irreversible alpha adrenoceptor blocking effects and reversible muscarinic blocking and nicotinic blocking effects of tetramine disulfides on the heartB G Benfey, B Belleau, L Brasili, et al.
Drug Design and Delivery|May 1, 1988
Molecular requirements for antimuscarinic activity in 1,3-oxathiolanesP Angeli, D Bacchiocchi, M Giannella, et al.
Journal of Medicinal Chemistry|September 1, 1986
Resolution, absolute configuration, and cholinergic enantioselectivity of (+)- and (-)-cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodideE Teodori, F Gualtieri, P Angeli, et al.
Pageof 7